Stay updated on Psilocybin vs Niacin for Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.

Latest updates to the Psilocybin vs Niacin for Depression Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, signaling a minor site update. This change does not modify the study details or how the page operates for users.SummaryDifference0.1%

- Check12 days agoChange DetectedAdds the PSIL201-LTFU long-term follow-up study details, including its title, observational design, dosing context (psilocybin vs niacin), sample size (26), site and sponsor (Usona Institute), and the study director. It also specifies the primary outcome (MADRS) and the planned timepoints, clarifying how this follow-up study is structured.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor platform release rather than changes to the study record (e.g., outcomes, eligibility, or dates).SummaryDifference0.1%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Psilocybin vs Niacin for Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.